Insulin Savings for Patients Act
Sponsored By: Representative Burgess, Michael C. [R-TX-26]
Unknown
Summary
Insulin Savings for Patients Act This bill requires 100% of negotiated price concessions for covered insulin products under the Medicare prescription drug benefit to be reflected at the point of sale by 2024. The Government Accountability Office must annually report on the effects of the bill's implementation, including with respect to insulin prices.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
No Economic Impacts Identified for this Bill
Sponsors & CoSponsors
Sponsor
Burgess, Michael C. [R-TX-26]
TX • R
Cosponsors
Rep. Miller-Meeks, Mariannette [R-IA-1]
IA • R
Sponsored 2/18/2022
Rep. McKinley, David B. [R-WV-1]
WV • R
Sponsored 3/30/2022
Rep. Van Drew, Jefferson [R-NJ-2]
NJ • R
Sponsored 3/31/2022
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov